技術(shù)外包服務(wù):

★蛋白激酶C α抗體品牌 分子生物學(xué)：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué)：基因合成、引物合成、基因測序、載體構(gòu)建等

★蛋白工程：原核、哺乳動物蛋白表達(dá)系統(tǒng)等

★病毒包裝：腺病毒、慢病毒等

★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等

★細(xì)胞工程：細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。

實驗流程：

蛋白激酶C α抗體品牌 英文名稱  Anti-PKC alpha

中文名稱  蛋白激酶C α抗體品牌 

別    名 AAG6; Aging associated gene 6; KPCA_HUMAN; MGC129900; MGC129901; PICK 1; PKC A; PKC alpha; PKC alpha; PKC-A; PKC-alpha; PKCA; PRKACA; PRKC A; PRKCA; Protein Kinase C alpha; Protein kinase C alpha type.

產(chǎn)品屬性：

濃    度  1mg/1ml

規(guī) 格  0.2ml/200μg

抗體來源  Rabbit

克隆類型   polyclonal

交叉反應(yīng)   Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit, Sheep

產(chǎn)品類型   一抗  

研究領(lǐng)域     免疫學(xué) 信號轉(zhuǎn)導(dǎo) 激酶和磷酸酶

蛋白分子量  predicted molecular weight: 77kDa 

性    狀   Lyophilized or Liquid

免 疫 原  KLH conjugated synthetic peptide derived from human PKC alpha

亞    型  IgG

純化方法   affinity purified by Protein A

儲 存 液   0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide

蛋白激酶C α抗體品牌 產(chǎn)品應(yīng)用   WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

產(chǎn)品介紹 Protein Kinase c alpha (PKC alpha) is an 77 kDa member of the conventional group (cPKCs: sensitive to calcium, diacylglycerol, phosphatidylserine and phorbol esters) of the PKC family of serine/ threonine kinases that are involved in a wide range of physiological processes including mitogenesis, cell survival and transcriptional regulation. PKC alpha is an ubiquitously expressed PKC isozyme that has been implicated in the regulation of a broad range of cellular functions including proliferation, differentiation, development, migration, cell cell adhesion, cell extracellular matrix adhesion, and solute transport. The activation loop threonine (threonine 497 in PKC alpha) of conventional PKCs is phosphorylated by phosphoinositide dependent kinase 1 (PDK1). This phosphorylation is necessary for the autophosphorylation of threonine 638 in the carboxy terminus of PKC alpha, a step that is critical for regulating the rate of PKC alpha dephosphorylation and inactivation.

Function : [FUNCTION] Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that is involved in positive and negative regulation of cell proliferation, apoptosis, differentiation, migration and adhesion, tumorigenesis, cardiac hypertrophy, angiogenesis, platelet function and inflammation, by directly phosphorylating targets such as RAF1, BCL2, CSPG4, TNNT2/CTNT, or activating signaling cascade involving MAPK1/3 (ERK1/2) and RAP1GAP. Involved in cell proliferation and cell growth arrest by positive and negative regulation of the cell cycle. Can promote cell growth by phosphorylating and activating RAF1, which mediates the activation of the MAPK/ERK signaling cascade, and/or by up-regulating CDKN1A, which facilitates active cyclin-dependent kinase (CDK) complex formation in glioma cells. In intestinal cells stimulated by the phorbol ester PMA, can trigger a cell cycle arrest program which is associated with the accumulation of the hyper-phosphorylated growth-suppressive form of RB1 and induction of the CDK inhibitors CDKN1A and CDKN1B. Exhibits anti-apoptotic function in glioma cells and protects them from apoptosis by suppressing the p53/TP53-mediated activation of IGFBP3, and in leukemia cells mediates anti-apoptotic action by phosphorylating BCL2. During macrophage differentiation induced by macrophage colony-stimulating factor (CSF1), is translocated to the nucleus and is associated with macrophage development. After wounding, translocates from focal contacts to lamellipodia and participates in the modulation of desmosomal adhesion. Plays a role in cell motility by phosphorylating CSPG4, which induces association of CSPG4 with extensive lamellipodia at the cell periphery and polarization of the cell accompanied by increases in cell motility. Is highly expressed in a number of cancer cells where it can act as a tumor promoter and is implicated in malignant phenotypes of several tumors such as gliomas and breast cancers. Negatively regulates myocardial contractility and positively regulates angiogenesis, platelet aggregation and thrombus formation in arteries. Mediates hypertrophic growth of neonatal cardiomyocytes, in part through a MAPK1/3 (ERK1/2)-dependent signaling pathway, and upon PMA treatment, is required to induce cardiomyocyte hypertrophy up to heart failure and death, by increasing protein synthesis, protein-DNA ratio and cell surface area. Regulates cardiomyocyte function by phosphorylating cardiac troponin T (TNNT2/CTNT), which induces significant reduction in actomyosin ATPase activity, myofilament calcium sensitivity and myocardial contractility. In angiogenesis, is required for full endothelial cell migration, adhesion to vitronectin (VTN), and vascular endothelial growth factor A (VEGFA)-dependent regulation of kinase activation and vascular tube formation. Involved in the stabilization of VEGFA mRNA at post-transcriptional level and mediates VEGFA-induced cell proliferation. In the regulation of calcium-induced platelet aggregation, mediates signals from the CD36/GP4 receptor for granule release, and activates the integrin heterodimer ITGA2B-ITGB3 through the RAP1GAP pathway for adhesion. During response to lipopolysaccharides (LPS), may regulate selective LPS-induced macrophage functions involved in host defense and inflammation. But in some inflammatory responses, may negatively regulate NF-kappa-B-induced genes, through IL1A-dependent induction of NF-kappa-B inhibitor alpha (NFKBIA/IKBA). Upon stimulation with 12-O-tetradecanoylphorbol-13-acetate (TPA), phosphorylates EIF4G1, which modulates EIF4G1 binding to MKNK1 and may be involved in the regulation of EIF4E phosphorylation. Phosphorylates KIT, leading to inhibition of KIT activity.

Subunit : Recruited in a circadian manner into a nuclear complex which also includes BMAL1 and GNB2L1/RACK1 (By similarity). Interacts with ADAP1/CENTA1, CSPG4 and PRKCABP. Binds to SDPR in the presence of phosphatidylserine. Interacts with PICK1 (via PDZ domain). Interacts with TRIM41.

Subcellular Location : Cytoplasm. Cell membrane; Peripheral membrane protein. Nucleus.

Contains 1 AGC-kinase C-terminal domain.

Contains 1 C2 domain.

Contains 2 phorbol-ester/DAG-type zinc fingers.

Contains 1 protein kinase domain.

Database links : UniProtKB/Swiss-Prot: P17252.4

全、新、優(yōu)、品、好四大特點：

蛋白激酶C α抗體品牌 全：公司提供上萬種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標(biāo)準(zhǔn)品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細(xì)胞等，基本上各種科研所需產(chǎn)品在我司都能找到。

新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。

優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。

好：我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊，產(chǎn)品一旦售出，實驗過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時沒有任何的后顧之憂。

正在熱銷的相關(guān)產(chǎn)品：

Anti-phospho-ATF2(Thr69/71) /FITC 熒光素標(biāo)記兔抗人、大、小鼠、猴磷酸化活化復(fù)制因子2(phospho ATF 2)抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Anti-GABAB2/FITC 熒光素標(biāo)記抗g-氨基B2受體抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh CMYA2/PDE4DIP 相關(guān)蛋白2 規(guī)格 0.2ml

NF-H(Neurofilament triplet H) 高分子量神經(jīng)絲蛋白(抗原) 0.5mg

IFI16 英文名稱： Gamma干擾素誘導(dǎo)蛋白16抗體 0.2ml

Rhesus antibody Rh TRPV4/TRP12 瞬時受體電位蛋白12抗體 規(guī)格 0.2ml

Anti-GABAB2/FITC 熒光素標(biāo)記抗g-氨基B2受體抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Human Insulin Receptor Beta,ISR- Beta ELISA KIT 人受體βMulti-class antibodies規(guī)格： 48T

Anti-Phospho-SGK1 (Ser78) 磷酸化糖皮質(zhì)激素調(diào)節(jié)激酶1抗體Multi-class antibodies規(guī)格： 0.1ml

Rhesus antibody Rh GPR109A/Puma gamma G蛋白偶聯(lián)受體109A抗體 規(guī)格 0.2ml

TAT ELISA Kit 大鼠凝血酶抗凝血酶復(fù)合物 96T

OCIAD2 英文名稱： 免疫反應(yīng)抗原抗體 0.2ml

BASC4 英文名稱： 癌擴(kuò)增序列蛋白4抗體 0.2ml

Anti-Phospho-SGK1 (Ser78) 磷酸化糖皮質(zhì)激素調(diào)節(jié)激酶1抗體Multi-class antibodies規(guī)格： 0.1ml

IFN- Alpha ELISA Kit 大鼠α干擾素Multi-class antibodies規(guī)格： 48T

Anti-VAMP-3 囊泡相關(guān)膜蛋白3抗體Multi-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh GATA-4 GATA結(jié)合蛋白4抗體 規(guī)格 0.1ml

HK ELISA Kit 大鼠己糖激酶 96T

Phospho-NMDAR2B (Tyr1474) 英文名稱： 磷酸化谷酸受體2B抗體 0.1ml

Adropin 英文名稱： 能量平衡相關(guān)蛋白抗體 0.2ml

Anti-VAMP-3 囊泡相關(guān)膜蛋白3抗體Multi-class antibodies規(guī)格： 0.2ml

CL-0119HuH-6(人肝母細(xì)胞瘤細(xì)胞)5×106cells/瓶×2

IgG3 Others Mouse 小鼠 IgG3-Fc 人細(xì)胞裂解液 (陽性對照)

小鼠肝內(nèi)膽管上皮細(xì)胞完全培養(yǎng)基 100mL

MC3T3-E1 Subclone 14小鼠顱頂前骨細(xì)胞亞克隆14 MC3T3-E1 Subclone 14 in mouse parietal bone cell sub clone 14 before a-MEM培養(yǎng)基+10%FBS

OSM Protein Mouse 重組小鼠 Oncostatin M / OSM 蛋白 (His 標(biāo)簽)

RS1(大鼠皮膚成纖維樣細(xì)胞) 5×106cells/瓶×2 THP-1(人單核細(xì)胞)

CL-0116HSC-T6(大鼠肝星形細(xì)胞)5×106cells/瓶×2

RK1 Others Rat 大鼠 kA / RK1 人細(xì)胞裂解液 (陽性對照)

人淋巴內(nèi)皮細(xì)胞裂解物HLECL

A2780/Taxol細(xì)胞，人紫杉醇耐藥株 鼠腹水單核細(xì)胞瘤,J774A.1細(xì)胞 組織源性原代細(xì)胞Many types of cells包裝：5 × 105次方(1ml)/1ml

Caki-2(人腎透明細(xì)胞癌細(xì)胞) 5×106cells/瓶×2

HBdSMC Pellet 人膀胱平滑肌細(xì)胞團(tuán)塊 > 1 mio.cells 人腦膜細(xì)胞cDNAHMC cDNA

蛋白激酶C α抗體品牌 IGFBP4 Others Cynomolgus 食蟹猴 IGFBP4 人細(xì)胞裂解液 (陽性對照)

大鼠腎上腺嗜鉻細(xì)胞瘤細(xì)胞;PC-12 [PC12]

肝竇內(nèi)皮細(xì)胞Many types of cells包裝：5 × 105次方(1ml)

Hat-78細(xì)胞，人T細(xì)胞 小鼠細(xì)胞,Ranca細(xì)胞 人食道平滑肌細(xì)胞cDNAHESMC cDNA

NEC(人細(xì)胞) 5×106cells/瓶×2

COLO 320(人細(xì)胞) 5×106cells/瓶×2 CL-0166NCI-H1650(人非小細(xì)胞細(xì)胞)5×106cells/瓶×2 大鼠肺泡巨噬細(xì)胞;NR8383[AgC11x3A; NR8383.1]